methylxanthine

tumor necrosis factor ; Homo sapiens







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 10321674 Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial. 1999 Apr 1
2 9067700 Pentoxifylline reduces the formation of sunburn cells. 1997 Feb 1
3 9160673 Pentoxifylline promotes replication of human cytomegalovirus in vivo and in vitro. 1997 May 15 1
4 8865286 Effects of treatment with pentoxifylline on the cardiovascular manifestations of group B streptococcal sepsis in the piglet. 1996 Sep 1
5 9172017 Differential regulation of TNF alpha, IL-1 beta, IL-6, IL-8, TNF beta, and IL-10 by pentoxifylline. 1996 Dec 2
6 8655288 Methylxanthines with adenosine alter TNF alpha-primed PMN activation. 1995 Nov 1
7 7835945 Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells. 1994 Oct 1
8 7678547 Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: a pilot study. 1993 2
9 7682199 Inhibition of CD44, CD45 and LFA-3 mediated cytokine release from human monocytes by SK&F 86002 and pentoxifylline. 1993 Feb 1
10 8409522 Pentoxifylline suppresses irritant and contact hypersensitivity reactions. 1993 Oct 1
11 1385797 Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells. 1992 May 1
12 2460096 Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. 1988 Sep 30 2